New Jersey and federal law bar false or misleading OTC drug ads, including cure claims, implied prescription strength, guaranteed or instant relief and misleading endorsements.
What is NJ OTC Drug Marketing - State Board of Pharmacy?
New Jersey and federal law bar false or misleading OTC drug ads, including cure claims, implied prescription strength, guaranteed or instant relief and misleading endorsements. Use on any asset promoting a specific OTC drug to New Jersey consumers. This guide summarizes the supplied rule information for marketing review. Use the linked official source to confirm the current text, applicability and
general_audience, general_adults_18plus, customers · OTC Drug · pharma
Where does this rule apply?
New Jersey · United States
Which marketing channels are covered?
all_channels
When does this rule take effect?
2026-05-10
What does this rule require?
New Jersey and federal law bar false or misleading OTC drug ads, including cure claims, implied prescription strength, guaranteed or instant relief and misleading endorsements.
How can marketing teams comply?
Use on any asset promoting a specific OTC drug to New Jersey consumers.
What is NJ OTC Drug Marketing - State Board of Pharmacy?
New Jersey and federal law bar false or misleading OTC drug ads, including cure claims, implied prescription strength, guaranteed or instant relief and misleading endorsements.
Who does this rule apply to?
general_audience, general_adults_18plus, customers · OTC Drug · pharma
Alabama's medical cannabis program (Alabama Medical Cannabis Commission (AMCC)) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Arkansas's medical cannabis program (Arkansas Medical Marijuana Commission) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Hawaii's medical cannabis program (Hawaii Department of Health — Medical Cannabis Registry) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Iowa's medical cannabis program (Iowa Department of Health and Human Services (Iowa HHS), Office of Medical Cannabidiol) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Kentucky's medical cannabis program (Kentucky Cabinet for Health and Family Services — Office of Medical Cannabis) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Louisiana's medical cannabis program (Louisiana Department of Health — Medical Marijuana Program) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Request a free compliance scan of your homepage and book a time with Warrant.